About/Juvenile Diabetes/San Diego/Researching Type 1 Diabetes
JDRF is leading the way in establishing measurement guidelines and holding itself accountable to supporters. JDRF has developed transparent organizational goals, as well as a set of research and advocacy objectives and outcomes for the current year by which organizational success will be measured. Measurements include:
– Initiating new clinical trials for artificial pancreas systems
– Developing new approaches to encapsulating islets
– Beginning proof-of-concept clinical trials with existing islet encapsulation approaches
– Trials demonstrating slowing progression of T1D in at-risk patients
– Effectiveness of approved T2D drugs tested in T1D
– Partnering to develop new T1D biomarkers
– Congress enacts $150 million extension of Special Diabetes Program at the National Institutes of Health Video Credits Column http://broadcaster.beazil.net/public/credits/youtube/videos/41488 Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. Type 1 diabetes (Juvenile Diabetes) is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. Only 5% of people with diabetes have this form of the disease.
In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.
18.2 million people in the United States (6.3 percent of the population) have been diagnosed with diabetes. 5 to 10 percent of all people with diabetes have Type 1 Diabetes (T1D). San Diego, “America’s Finest City,” is California’s sixth largest, with a city population exceeding 1.2 million.
San Diego is both a modern metropolis, with the accompanying cultural advantages, as well as a year-round resort. The Pacific Ocean, the Borrego Desert, the Cuyamaca Mountains and Tijuana, Mexico are all within an hour’s drive.
San Diego is the seat of the Univ. of California at San Diego, San Diego State University, United States International Univ., the Univ. of San Diego, Electronic Technical Institute, Scripps Institution of Oceanography and the Salk Institute for Biological Sciences. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
It makes sense to mention the main issues –
nonprofit funder,get support,blindness,insulin glargine,make a contribution,complications of diabetes,Traveling with Diabetes,Juvenile Diabetes charity,Political advocacy,diabetic mastopathy,cholesterol levels,young adult diabetes,join,raise money,Cal.,Hypers,CFRD,Special Diabetes Program,The Eldorado State,Bolus Basel,Translating Research Into Action for Diabetes Study,implantable insulin pump,Ride to Cure Diabetes,proinsulin,Estrogen in Type 1 Diabetes,Calif.,juvenile-onset diabetes,oral hypoglycemic agents,glyburide,Diabetes Complication,become an advocate,latent autoimmune diabetes in adults,World without T1D,Kidney Disease,Incretin-Based Therapies,SDP,Carb Counting,fasting plasma glucose value,rosiglitazone,Bag of Hope,Aldesleukin,High Blood Sugar,Humalog,Aaron Kowalski,glycemic control,Glucose,Children’s Congress,make a tax-deductive donation,UK Prospective Diabetes Study,noninsulin-dependent diabetes mellitus,support,Insulin,Chapter Volunteer Outreach Chairs,T1D Mentors,Research Pathways,The Grape State,World diabetes day,The Hyperglycemia and Adverse Pregnancy Outcome Study,impaired glucose tolerance,funding research,VLDL cholesterol,ACCORD Trial,US-CA,Weight Loss Support,cure therapies,T1D Progression,care delivery.